Biohaven Pharmaceutical Holding Co Ltd. 3 SEC Filings

Filed On	Filing
28 Sep 2022	Form 3: Biohaven Pharmaceutical Holding Co Ltd., 10% owner · Biohaven Ltd. Holds 100 shares of Common Shares
11 May 2022	Form 3: Antonijevic Irina, Director No securities owned
14 Dec 2021	Form 3: Buten Matthew, Officer No securities owned
13 Aug 2021	Form 3: Clark George C., VP, Chief Accounting Officer Holds 5,558 shares of Common Shares
17 Jun 2021	Form 3: Mehta Kishan, Director Holds 8,765 shares of Common Shares
12 Jun 2020	Form 3: Hugin Robert J, Director Holds 2,900 shares of Common Shares
31 Jan 2020	Form 3: Heffernan Michael Thomas, Director Holds 0 shares of No securities beneficially owned
19 Aug 2019	Form 3: Stock Elyse, Chief Medical Officer
03 Apr 2019	Form 3: Jones William A Jr, CCO-Migraine & Common Disease No securities owned
11 Sep 2018	Form 3: Repella Robert, Director Holds 0 shares of No securities beneficially owned
04 Aug 2017	Form 3: Gregory Julia P, Director Holds 0 shares of No securities beneficially owned
03 May 2017	Form 3: Bailey Gregory, Director Holds 39,000 shares of Common Shares
03 May 2017	Form 3: Tilton John, Chief Commercial Officer
03 May 2017	Form 3: Portage Biotech Inc., 10% owner Holds 6,341,500 shares of Common Shares
03 May 2017	Form 3: Gentile Kimberly, VP of Operations
03 May 2017	Form 3: Engelhart James, Chief Financial Officer
03 May 2017	Form 3: Doogan Declan, Director Holds 1,300,000 shares of Common Shares
03 May 2017	Form 3: Coric Vlad, Director Holds 650,000 shares of Common Shares
03 May 2017	Form 3: Conway Charles, Chief Scientific Officer
03 May 2017	Form 3: Childs John W, Director Holds 1,268,500 shares of Common Shares

Comments